Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, characterized by its aggressive progression and dismal prognosis. Advances in epigenetic profiling, specifically DNA methylation analysis, have significantly deepened our understanding of PDAC pathogenesis. This rev...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peiyi Liu, Juliette Jacques, Chang-Il Hwang
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Epigenomes
Subjects:	DNA methylation pancreatic ductal adenocarcinoma pancreatic cancer whole-genome bisulfite sequencing metastasis
Online Access:	https://www.mdpi.com/2075-4655/8/4/41
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Circulating cell‐free DNA methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma
by: Guochao Zhao, et al.
Published: (2024-11-01)

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
by: Ritu R. Singh, et al.
Published: (2023-02-01)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01)

Botanical drugs and their natural compounds: a neglected treasury for inhibiting the carcinogenesis of pancreatic ductal adenocarcinoma
by: Yunfei Dai, et al.
Published: (2024-12-01)

FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival
by: Nathalie B. Rasko, et al.
Published: (2025-01-01)

Realising the therapeutic potential of the human microbiota in metastatic pancreatic ductal adenocarcinoma
by: James M. Halle-Smith, et al.
Published: (2023-12-01)

Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment
by: Wojciech Ciesielski, et al.
Published: (2024-11-01)

Niraparib perturbs autophagosome-lysosome fusion in pancreatic ductal adenocarcinoma and exhibits anticancer potential against gemcitabine-resistant PDAC
by: Zehui Yao, et al.
Published: (2025-01-01)

Association between preoperative exercise tolerance and unplanned readmission in patients who underwent pancreatectomy for pancreatic ductal adenocarcinoma: a retrospective analysis
by: Makoto Onji, et al.
Published: (2025-01-01)

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas
by: William A. Ziaziaris, et al.
Published: (2024-12-01)

Identification of SMAD4-mutated pancreatic ductal adenocarcinoma using preoperative contrast-enhanced MRI and clinical characteristics
by: Zhina Li, et al.
Published: (2024-12-01)

Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma
by: Qingqing Li, et al.
Published: (2019-12-01)

Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma
by: Metoboroghene O. Mowoe, et al.
Published: (2025-01-01)

Epigenetic Activation of the CMTM6‐IGF2BP1‐EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
by: Ying‐Qin Zhu, et al.
Published: (2024-12-01)

Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients
by: Lingyi Fu, et al.
Published: (2025-02-01)

Microbiome in pancreatic cancer – What is new in 2024?
by: E. Hohmann, et al.
Published: (2024-10-01)

Textbook outcomes among patients undergoing curative resection of pancreatic ductal adenocarcinoma in the era of neoadjuvant therapy
by: Lingyu Zhu, et al.
Published: (2023-06-01)

Single-cell transcriptomics reveal the prognostic roles of epithelial and T cells and DNA methylation-based prognostic models in pancreatic cancer
by: Jing Du, et al.
Published: (2024-12-01)

Diagnosis of Pancreatic Ductal Adenocarcinoma Using Deep Learning
by: Fulya Kavak, et al.
Published: (2024-10-01)

Comparison of multiple machine learning models for predicting prognosis of pancreatic ductal adenocarcinoma based on contrast-enhanced CT radiomics and clinical features
by: Yue Huang, et al.
Published: (2024-11-01)

Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling
by: Qian Du, et al.
Published: (2024-12-01)

Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
by: Heng‐Chung Kung, et al.
Published: (2023-04-01)

Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study
by: Neil Daniel, et al.
Published: (2024-10-01)

GNG12 regulates PD‐L1 expression by activating NF‐κB signaling in pancreatic ductal adenocarcinoma
by: Juan Li, et al.
Published: (2020-02-01)

A collagenase-decorated Cu-based nanotheranostics: remodeling extracellular matrix for optimizing cuproptosis and MRI in pancreatic ductal adenocarcinoma
by: Yining Wang, et al.
Published: (2024-11-01)

Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients
by: Xiao Liang, et al.
Published: (2024-12-01)

Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
by: Daniel Oyon, et al.
Published: (2025-01-01)

Assessing the diagnostic potential of SATB2 and β-catenin as biomarkers and therapeutic targets in pancreatic ductal adenocarcinoma
by: Noha Said Helal, et al.
Published: (2025-01-01)

CASC8 activates the pentose phosphate pathway to inhibit disulfidptosis in pancreatic ductal adenocarcinoma though the c-Myc-GLUT1 axis
by: Hong-Fei Yao, et al.
Published: (2025-01-01)

Multiphoton imaging-based quantifiable collagen signatures for predicting outcomes in patients with pancreatic ductal adenocarcinoma
by: Xiwen Chen, et al.
Published: (2025-02-01)

Evaluation of the Anti-Cancer Efficacy of Cyclooxygenase Inhibition in Combination with Nutrient Starvation on Pancreatic Ductal Adenocarcinoma <em>In Vitro</em>
by: Ayşe Nur Çaldıran, et al.
Published: (2024-12-01)

Familial Pancreatic Cancer Research: Bridging Gaps in Basic Research and Clinical Application
by: Suyakarn Archasappawat, et al.
Published: (2024-10-01)

Novel machine‐learning model for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma
by: Susumu Daibo, et al.
Published: (2025-01-01)

Real-world clinical outcome of unresectable locally advanced & de-novo metastatic pancreatic ductal adenocarcinoma: a multicentre retrospective study
by: Mohamed Aseafan, et al.
Published: (2025-01-01)

Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma
by: Wei Wei, et al.
Published: (2024-12-01)

Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma
by: John G. Yuen, et al.
Published: (2024-03-01)

A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma
by: Bo Li, et al.
Published: (2025-02-01)

Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients
by: Charlotte Maulat, et al.
Published: (2024-11-01)

Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Clinical CA209-9KH Trial
by: Milan Vošmik, et al.
Published: (2024-10-01)

It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
by: Christin Knickmeier, et al.
Published: (2025-01-01)